Table 2.
Physical activity and Fitbit wear distribution in the sample of breast cancer patients (N = 32)
| Variable | Mean (SD) |
|---|---|
| Days with Fitbit weara | 102.5 (48.42) |
| Percent of chemotherapy days with Fitbit wear | 84.0 (20.10) |
| Chemotherapy overall | |
| Fitbit wear hr/dayb | 12.9 (2.69) |
| MVPA min/day | 10.5 (9.43) |
| Total PA min/day | 189.1 (77.15) |
| 0%–10% of chemotherapyc | |
| Fitbit wear hr/dayb | 13.9 (2.80) |
| MVPA min/day | 15.2 (15.42) |
| Total PA min/day | 203.5 (89.75) |
| 45%–55% of chemotherapyc | |
| Fitbit wear hr/dayb | 12.4 (4.11) |
| MVPA min/day | 9.7 (11.00) |
| Total PA min/day | 183.8 (82.82) |
| 90%–100% of chemotherapyc | |
| Fitbit wear hr/dayb | 12.8 (3.57) |
| MVPA min/day | 7.2 (8.72) |
| Total PA min/day | 172.4 (93.01) |
aDays with > 5 min of wear
bNon-sleep wear
cDistribution at proportion of chemotherapy completed